Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
45
MSTR Quote, Financials, Valuation and Earnings
Last price:
$364.46
Seasonality move
:
20.68%
Day range:
$317.00 - $364.88
52-week range:
$43.87 - $543.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
151.04x
P/B ratio:
21.68x
Volume:
44.2M
Avg. volume:
35.7M
1-year change:
535.08%
Market cap:
$81.8B
Revenue:
$496.3M
EPS (TTM):
-$2.11
Earnings Data
Next earnings date for MSTR
Feb 06
2025
Most recent earnings per share
-$1.72
Missed by $1.70
(Oct 30/2024)
Consensus Estimate
-$0.02
(Oct 30/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MSTR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/06/2025 | Q4 | $123.5M | -- | -- | $0.06 | -- |
| 10/30/2024 | Q3 | $121.5M | $116.1M | -$1.72 | -$0.02 | -$1.70 |
| 08/01/2024 | Q2 | $122M | $111.4M | -$0.57 | -$0.02 | -$0.55 |
| 04/29/2024 | Q1 | $121.4M | $115.2M | -$0.31 | -$0.01 | -$0.30 |
| 02/06/2024 | Q4 | $132.2M | $124.5M | $0.50 | $0.02 | $0.47 |
| 11/01/2023 | Q3 | $126.4M | $129.5M | -$1.01 | $0.07 | -$1.08 |
| 08/01/2023 | Q2 | $124.7M | $120.4M | $0.15 | $0.07 | $0.08 |
| 05/01/2023 | Q1 | $119M | $121.9M | $3.18 | $0.03 | $3.15 |
| 02/02/2023 | Q4 | $131M | $132.6M | -$2.19 | $0.10 | -$2.29 |
| 11/01/2022 | Q3 | -- | $125.4M | -$0.24 | -- | -- |
| 08/02/2022 | Q2 | -- | $122.1M | -$9.40 | -- | -- |
| 05/03/2022 | Q1 | -- | $119.3M | -$1.16 | -- | -- |
| 02/01/2022 | Q4 | -- | $134.5M | -$0.84 | -- | -- |
| 10/28/2021 | Q3 | -- | $128M | -$0.36 | -- | -- |
| 07/29/2021 | Q2 | -- | $125.4M | -$3.07 | -- | -- |
| 04/29/2021 | Q1 | -- | $122.9M | -$1.14 | -- | -- |
| 01/28/2021 | Q4 | -- | $131.3M | $0.03 | -- | -- |
| 10/27/2020 | Q3 | -- | $127.4M | -$0.15 | -- | -- |
| 07/28/2020 | Q2 | -- | $110.6M | $0.04 | -- | -- |
| 03/31/2020 | Q1 | -- | $111.4M | $0.01 | -- | -- |
| 12/31/2019 | Q4 | -- | $133.5M | $0.12 | -- | -- |
| 10/29/2019 | Q3 | -- | $119.7M | $0.09 | -- | -- |
| 07/30/2019 | Q2 | -- | $117.7M | $0.20 | -- | -- |
| 04/30/2019 | Q1 | -- | $115.4M | -$0.08 | -- | -- |
| 01/29/2019 | Q4 | -- | $131.9M | $0.03 | -- | -- |
| 10/25/2018 | Q3 | -- | $122.2M | $0.11 | -- | -- |
| 07/26/2018 | Q2 | -- | $120.6M | $0.04 | -- | -- |
| 04/26/2018 | Q1 | -- | $123M | $0.02 | -- | -- |
| 01/25/2018 | Q4 | -- | $136.4M | -$0.23 | -- | -- |
| 10/26/2017 | Q3 | -- | $126M | $0.16 | -- | -- |
| 07/27/2017 | Q2 | -- | $119.2M | $0.09 | -- | -- |
| 04/27/2017 | Q1 | -- | $122.2M | $0.13 | -- | -- |
| 01/31/2017 | Q4 | -- | $141.5M | $0.27 | -- | -- |
| 10/27/2016 | Q3 | -- | $129.9M | $0.23 | -- | -- |
| 07/28/2016 | Q2 | -- | $123.1M | $0.16 | -- | -- |
| 04/27/2016 | Q1 | -- | $119M | $0.12 | -- | -- |
| 01/27/2016 | Q4 | -- | $143.5M | $0.34 | -- | -- |
| 10/26/2015 | Q3 | -- | $129.5M | $0.21 | -- | -- |
| 07/27/2015 | Q2 | -- | $132.9M | $0.20 | -- | -- |
| 04/28/2015 | Q1 | -- | $123.9M | $0.18 | -- | -- |
| 01/26/2015 | Q4 | -- | $148.9M | $0.20 | -- | -- |
MicroStrategy Earnings Questions
-
How Much did MicroStrategy Generate in Revenue Last Quarter?
MicroStrategy reported $116.1M worth of top line sales in its most recent quarter.
-
Did MicroStrategy Beat Earnings Last Quarter?
MicroStrategy announced earnings per share of -$1.72 which represents a miss of analyst forecast a -$0.02 per share.
-
Is MicroStrategy Profitable?
MicroStrategy reported $81.7M that represents $0.41 per share over the last quarter.
-
What is the Analyst Consensus for MicroStrategy EPS Next Year?
MicroStrategy's earnings are forecast to decrease from $2.64 per share to $2.68 per share next year representing a decrease of -94.06%.
-
When is MicroStrategy's Earnings Date?
MicroStrategy's next earnings date is February 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
